Global Vaccines & Vaccination Market Worth $769.4 Million by 2022 - Rising Use of Adjuvants in Vaccine-Preventable Diseases - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Vaccines & Vaccination Market Insights, Opportunity, Analysis, Market Shares and Forecast 2016 - 2022" report to their offering.

The global vaccines & vaccination market is expected to grow at the CAGR of 10.5% during 2016-2022. The market has generated revenue of more than $467 million in 2016 and is projected to reach up to $769.4 million by 2022.

Due to rising use of adjuvants in vaccine-preventable diseases, increasing government investments and initiatives, rising company investments in vaccine development and increasing initiatives by non-government organizations become the major drivers which help to increase the market of vaccines & vaccination globally. Due to increasing prevalence of diseases such as HIV/AIDS, cancer and allergy, there is an increase in the demand of adjuvants vaccine.

According to American Academy of Allergy Asthma and Immunology (AAAAI), around 7.8 million children suffered from respiratory allergies worldwide. It is seen that more than 8% population is suffering from food allergy, globally, among which approximately 6% aged 0-2 years, 9% aged 3-5 years and nearly 8% aged 6-10 years, approximately 8% aged 11-13 years and more than 8.5% aged 14-18 years suffer from food allergy globally.

Geographically, the vaccines &vaccination market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America has the largest market share of vaccines & vaccination followed by Europe and Asia Pacific. Due to governmental initiatives, and increasing focus of major players in the Indian vaccine technology market, and increasing immunization initiatives by organizations such as World Health Organization and GAVI helps to increase the market of Asia Pacific region.

Companies Mentioned:

  • Abbott
  • Astrazeneca
  • Bavarian Nordic
  • Baxter
  • Bharat Biotech
  • Bio Med
  • Csl Limited
  • Emergent Biosolutions, Inc.
  • Glaxosmithkline, Plc
  • Johnson &Johnson
  • Medimmune, Llc. (A Subsidiary of Astrazeneca)
  • Merck &Co., Inc.
  • Novartis Ag
  • Pfizer, Inc.
  • Sanofi

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Geographical Technologies

6. Company Profiles

For more information visit http://www.researchandmarkets.com/research/4kdvtv/global_vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Vaccines